Trademark Overview
On Tuesday, May 13, 2025, a trademark application was filed for D-FI with the United States Patent and Trademark Office. The USPTO has given the D-FI trademark a serial number of 99182363. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 13, 2025. This trademark is owned by Castle Creek Biosciences, LLC. The D-FI trademark is filed in the Pharmaceutical Products category with the following description:
gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases